Despite this, the results obtained indicate that aminocarbazole semi-synthetic derivatives, particularly 3-(p-fluoro)aminoheptaphylline (1d), may represent a promising starting point to search for new mutant p53-reactivating agents with promising application in cancer therapy. Here, TP53 is linked to cancer.